FcRn binding and recycling of IgG and albumin have been exploited to develop therapeutic strategies for enhanced drug delivery, such as Fc or albumin conjugated with viral antigens for efficient delivery of vaccines or to block IgG recycling to improve treatments of autoimmune diseases [11,14,15,16]. The gene discussed is ALB; the disease is autoimmune disease.